Ginkgo Bioworks (DNA) Misses Q3 EPS by 12c

Ginkgo Bioworks (NYSE: DNA) reported Q3 EPS of ($0.41), $0.12 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $66.4 million versus the consensus estimate of $60.35 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c